Old Web
English
Sign In
Acemap
>
Paper
>
Update on proprotein convertase subtilisin/kexin type 9 inhibitors, lipoprotein(a) and cardiovascular risk.
Update on proprotein convertase subtilisin/kexin type 9 inhibitors, lipoprotein(a) and cardiovascular risk.
2021
Laurent O. Martinez
Bertrand Perret
Annelise Genoux
Keywords:
Proprotein convertase
Kexin
Internal medicine
Subtilisin
Endocrinology
Lipoprotein(a)
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
35
References
0
Citations
NaN
KQI
[]